Skip to Content

Evogene Ltd EVGN

Morningstar Rating
$0.84 0.00 (0.10%)
View Full Chart
Unlock Our Analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

EVGN is trading at a 56% discount.
Price
$0.85
Fair Value
$6.78
Uncertainty
Extreme
1-Star Price
$33.98
5-Star Price
$4.44
Economic Moat
Lvkf
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if EVGN is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$0.84
Day Range
$0.820.86
52-Week Range
$0.451.44
Bid/Ask
$0.81 / $0.86
Market Cap
$42.47 Mil
Volume/Avg
323,587 / 124,657

Key Statistics

Price/Earnings (Normalized)
Price/Sales
6.36
Dividend Yield
Dividend Yield (Forward)
Total Yield

Company Profile

Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules and genetic elements as the core components for such products. It holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Small Growth
Total Number of Employees
137

Valuation

Metric
EVGN
Price/Earnings (Normalized)
Price/Book Value
2.29
Price/Sales
6.36
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
EVGN
Quick Ratio
6.24
Current Ratio
6.25
Interest Coverage
−31.26
Quick Ratio
EVGN

Profitability

Metric
EVGN
Return on Assets (Normalized)
−37.81%
Return on Equity (Normalized)
−92.05%
Return on Invested Capital (Normalized)
−46.24%
Return on Assets
EVGN

Biotechnology Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
NVO
Novo Nordisk A/S ADRHnhy$445.3 Bil
VRTX
Vertex Pharmaceuticals IncMjgvt$91.1 Bil
REGN
Regeneron Pharmaceuticals IncQsytkp$91.1 Bil
SGEN
Seagen Inc Ordinary SharesGqrxt$40.7 Bil
MRNA
Moderna IncBrys$30.7 Bil
ARGX
argenx SE ADRJnlnm$27.7 Bil
BNTX
BioNTech SE ADRKtft$24.1 Bil
ALNY
Alnylam Pharmaceuticals IncNntldy$22.0 Bil
BMRN
Biomarin Pharmaceutical IncXzhjst$17.7 Bil
INCY
Incyte CorpJztpzf$12.4 Bil